One-Time gene therapy aims to halt rare, fatal brain disease in children
NCT ID NCT04713475
First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This study tests a single dose of PBGM01, a gene therapy delivered directly into the fluid around the brain and spinal cord, in children with GM1 gangliosidosis. The therapy uses a harmless virus to carry a working copy of the GLB1 gene, which is missing or faulty in these patients. The trial includes two groups: infants with the early-onset form (Type 1) and older infants with the late-onset form (Type 2a). Researchers will monitor safety and whether the treatment helps children reach developmental milestones.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PBGM01 (a gene therapy using a harmless virus to deliver a working GLB1 gene)
What this could lead to
If successful, this could provide a one-time treatment that slows or stops the progression of GM1 gangliosidosis, a devastating and currently untreatable disease.
What could go wrong
This is an early-phase trial with only 26 participants, so results may not apply to all patients. Gene therapies carry risks like immune reactions or the treatment not reaching all affected cells.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GM1 GANGLIOSIDOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Benioff Children's Hospital
Oakland, California, 94158, United States
-
Children's Hospital at St. Peter's University Hospital
New Brunswick, New Jersey, 08901, United States
-
Gazi University
Ankara, Turkey (Türkiye)
-
Great Ormond Street Hospital
London, United Kingdom
-
Hospital de Clínicas de Porto Alegre (HCPA)
Porto Alegre, Brazil
-
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States